Taken together, our data show a myokine-induced upregulation of caspase 3 and 7 expression and PARP cleavage, and an increase in PC cell apoptosis and death upon treatment with CXCL1/IL10/CCL4. The gene discussed is CASP3; the disease is pachyonychia congenita.